ALKEM LABORATORIES
|
ALKEM LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr |
| Equity - Authorised | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr |
| Equity - Issued | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr |
| Equity Paid Up | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | ₹36 Cr | ₹36 Cr | ₹20 Cr | ₹0.60 Cr | ₹0.60 Cr |
| Total Reserves | ₹13,761 Cr | ₹11,925 Cr | ₹10,269 Cr | ₹9,021 Cr | ₹8,613 Cr |
| Securities Premium | - | - | - | - | - |
| Capital Reserves | ₹0.52 Cr | ₹0.52 Cr | ₹0.52 Cr | ₹0.52 Cr | ₹0.52 Cr |
| Profit & Loss Account Balance | ₹11,662 Cr | ₹9,973 Cr | ₹8,310 Cr | ₹7,052 Cr | ₹6,594 Cr |
| General Reserves | ₹1,988 Cr | ₹1,987 Cr | ₹1,987 Cr | ₹1,987 Cr | ₹1,987 Cr |
| Other Reserves | ₹109 Cr | ₹-36 Cr | ₹-29 Cr | ₹-19 Cr | ₹32 Cr |
| Reserve excluding Revaluation Reserve | ₹13,761 Cr | ₹11,925 Cr | ₹10,269 Cr | ₹9,021 Cr | ₹8,613 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹13,820 Cr | ₹11,985 Cr | ₹10,312 Cr | ₹9,045 Cr | ₹8,638 Cr |
| Minority Interest | ₹529 Cr | ₹449 Cr | ₹402 Cr | ₹390 Cr | ₹209 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹40 Cr | ₹62 Cr | ₹40 Cr | - | ₹0.03 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹40 Cr | - | - | - | - |
| Term Loans - Institutions | - | ₹62 Cr | ₹40 Cr | - | ₹0.03 Cr |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | ₹453 Cr | ₹248 Cr | - | - | ₹9.35 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | ₹453 Cr | ₹248 Cr | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | ₹9.35 Cr |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-1,804 Cr | ₹-1,738 Cr | ₹-1,515 Cr | ₹-1,303 Cr | ₹-1,309 Cr |
| Deferred Tax Assets | ₹2,002 Cr | ₹1,971 Cr | ₹1,770 Cr | ₹1,498 Cr | ₹1,528 Cr |
| Deferred Tax Liability | ₹198 Cr | ₹233 Cr | ₹256 Cr | ₹196 Cr | ₹219 Cr |
| Other Long Term Liabilities | ₹803 Cr | ₹641 Cr | ₹526 Cr | ₹245 Cr | ₹74 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹431 Cr | ₹338 Cr | ₹300 Cr | ₹369 Cr | ₹333 Cr |
| Total Non-Current Liabilities | ₹-78 Cr | ₹-448 Cr | ₹-649 Cr | ₹-688 Cr | ₹-893 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹2,244 Cr | ₹1,937 Cr | ₹1,748 Cr | ₹1,165 Cr | ₹1,173 Cr |
| Sundry Creditors | ₹2,244 Cr | ₹1,937 Cr | ₹1,748 Cr | ₹1,165 Cr | ₹1,173 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹1,186 Cr | ₹1,068 Cr | ₹892 Cr | ₹839 Cr | ₹771 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹235 Cr | ₹220 Cr | ₹112 Cr | ₹74 Cr | ₹73 Cr |
| Interest Accrued But Not Due | - | - | - | - | ₹0.20 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹951 Cr | ₹848 Cr | ₹780 Cr | ₹765 Cr | ₹698 Cr |
| Short Term Borrowings | ₹1,085 Cr | ₹735 Cr | ₹1,173 Cr | ₹1,307 Cr | ₹2,571 Cr |
| Secured ST Loans repayable on Demands | ₹701 Cr | ₹424 Cr | ₹387 Cr | ₹301 Cr | ₹1,335 Cr |
| Working Capital Loans- Sec | ₹701 Cr | ₹424 Cr | ₹387 Cr | ₹301 Cr | ₹1,335 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-317 Cr | ₹-114 Cr | ₹398 Cr | ₹706 Cr | ₹-100 Cr |
| Short Term Provisions | ₹267 Cr | ₹220 Cr | ₹182 Cr | ₹396 Cr | ₹290 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹67 Cr | ₹61 Cr | ₹55 Cr | ₹23 Cr | ₹16 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹201 Cr | ₹159 Cr | ₹127 Cr | ₹373 Cr | ₹274 Cr |
| Total Current Liabilities | ₹4,783 Cr | ₹3,961 Cr | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr |
| Total Liabilities | ₹19,054 Cr | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr |
| ASSETS | |||||
| Gross Block | ₹6,070 Cr | ₹4,720 Cr | ₹4,544 Cr | ₹4,050 Cr | ₹4,186 Cr |
| Less: Accumulated Depreciation | ₹2,199 Cr | ₹1,867 Cr | ₹1,671 Cr | ₹1,367 Cr | ₹1,284 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹3,871 Cr | ₹2,852 Cr | ₹2,873 Cr | ₹2,683 Cr | ₹2,902 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹138 Cr | ₹477 Cr | ₹148 Cr | ₹310 Cr | ₹339 Cr |
| Non Current Investments | ₹1,132 Cr | ₹943 Cr | ₹335 Cr | ₹305 Cr | ₹232 Cr |
| Long Term Investment | ₹1,132 Cr | ₹943 Cr | ₹335 Cr | ₹305 Cr | ₹232 Cr |
| Quoted | ₹880 Cr | ₹710 Cr | ₹170 Cr | ₹143 Cr | ₹105 Cr |
| Unquoted | ₹251 Cr | ₹233 Cr | ₹164 Cr | ₹162 Cr | ₹127 Cr |
| Long Term Loans & Advances | ₹364 Cr | ₹278 Cr | ₹204 Cr | ₹139 Cr | ₹154 Cr |
| Other Non Current Assets | ₹1,195 Cr | ₹385 Cr | ₹79 Cr | ₹275 Cr | ₹697 Cr |
| Total Non-Current Assets | ₹6,843 Cr | ₹5,007 Cr | ₹3,648 Cr | ₹3,724 Cr | ₹4,325 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹737 Cr | ₹902 Cr | ₹149 Cr | ₹317 Cr | ₹139 Cr |
| Quoted | ₹737 Cr | ₹828 Cr | ₹47 Cr | ₹212 Cr | ₹31 Cr |
| Unquoted | ₹75 Cr | ₹75 Cr | ₹102 Cr | ₹122 Cr | ₹124 Cr |
| Inventories | ₹3,333 Cr | ₹2,922 Cr | ₹2,661 Cr | ₹2,608 Cr | ₹3,006 Cr |
| Raw Materials | ₹1,084 Cr | ₹927 Cr | ₹869 Cr | ₹806 Cr | ₹790 Cr |
| Work-in Progress | ₹239 Cr | ₹129 Cr | ₹147 Cr | ₹164 Cr | ₹134 Cr |
| Finished Goods | ₹1,360 Cr | ₹1,114 Cr | ₹829 Cr | ₹1,008 Cr | ₹1,344 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | ₹651 Cr | ₹753 Cr | ₹816 Cr | ₹629 Cr | ₹737 Cr |
| Sundry Debtors | ₹2,979 Cr | ₹2,466 Cr | ₹2,253 Cr | ₹2,132 Cr | ₹1,885 Cr |
| Debtors more than Six months | ₹208 Cr | ₹111 Cr | ₹213 Cr | ₹107 Cr | ₹95 Cr |
| Debtors Others | ₹2,907 Cr | ₹2,435 Cr | ₹2,132 Cr | ₹2,069 Cr | ₹1,836 Cr |
| Cash and Bank | ₹1,733 Cr | ₹1,563 Cr | ₹1,579 Cr | ₹2,617 Cr | ₹2,579 Cr |
| Cash in hand | ₹1.07 Cr | ₹1.17 Cr | ₹1.04 Cr | ₹0.76 Cr | ₹0.72 Cr |
| Balances at Bank | ₹1,696 Cr | ₹1,493 Cr | ₹1,569 Cr | ₹2,613 Cr | ₹2,516 Cr |
| Other cash and bank balances | ₹35 Cr | ₹69 Cr | ₹9.70 Cr | ₹2.82 Cr | ₹62 Cr |
| Other Current Assets | ₹221 Cr | ₹156 Cr | ₹237 Cr | ₹245 Cr | ₹240 Cr |
| Interest accrued on Investments | - | - | - | ₹90 Cr | ₹57 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹80 Cr | ₹60 Cr | ₹50 Cr | ₹44 Cr | ₹56 Cr |
| Other current_assets | ₹141 Cr | ₹97 Cr | ₹187 Cr | ₹110 Cr | ₹127 Cr |
| Short Term Loans and Advances | ₹3,207 Cr | ₹2,801 Cr | ₹3,532 Cr | ₹688 Cr | ₹586 Cr |
| Advances recoverable in cash or in kind | ₹142 Cr | ₹211 Cr | ₹192 Cr | ₹146 Cr | ₹74 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹3,065 Cr | ₹2,590 Cr | ₹3,340 Cr | ₹542 Cr | ₹512 Cr |
| Total Current Assets | ₹12,211 Cr | ₹10,811 Cr | ₹10,412 Cr | ₹8,606 Cr | ₹8,434 Cr |
| Net Current Assets (Including Current Investments) | ₹7,428 Cr | ₹6,851 Cr | ₹6,417 Cr | ₹4,899 Cr | ₹3,628 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹19,054 Cr | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr |
| Contingent Liabilities | ₹1,113 Cr | ₹881 Cr | ₹92 Cr | ₹285 Cr | ₹269 Cr |
| Total Debt | ₹1,624 Cr | ₹1,063 Cr | ₹1,214 Cr | ₹1,307 Cr | ₹2,580 Cr |
| Book Value | - | 999.47 | 860.94 | 756.56 | 722.48 |
| Adjusted Book Value | 1,153.04 | 999.47 | 860.94 | 756.56 | 722.48 |
Compare Balance Sheet of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹67,077.1 Cr | -2.5% | 0% | 11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -2.5% |
0% |
11.1% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses